UNSPSC 85613109: Revision of autologous tissue substitute in pancreatic duct, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in pancreatic duct, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FWD37Z

UNSPSC 85613109 Revision of autologous tissue substitute in pancreatic duct, percutaneous approach is a Commodity code that shows minimal alignment between its nominal scope and recent state and local solicitation activity. The code appears designed to classify a highly specialized surgical procedure involving pancreatic tissue intervention, but the recent opportunities tagged under this code instead reflect occupational health surveillance, pharmacy benefit management, medical staff augmentation, and pension-board disability medical evaluations—none of which involve pancreatic intervention or tissue revision. State and local procurement offices are tagging diverse healthcare service and benefits administration work under this code, suggesting a classification mismatch rather than genuine demand for the procedure the code names.

The geographic spread of recent activity spans Arizona (City of Phoenix), California (Long Beach, Santa Clara County, Collier County in Florida), Washington State, and Texas (Harris County), but the opportunities posted—including disability medical records summarization (due Oct 16, 2026), occupational medical surveillance for ferry workers (due Oct 9, 2026), pharmacy benefit management administration (due Apr 9, 2026), surgical benefit network carve-outs (due Oct 7, 2026), and temporary health professional staffing qualification pools (due Oct 7, 2026)—address administrative and staffing functions rather than the surgical procedure the code nominally describes. No recent opportunities reflect actual procurement of pancreatic revision services. Procurement professionals evaluating this code should treat it as substantially inactive for its stated purpose and conduct separate category searches for occupational medicine, medical staffing, and healthcare benefits administration using more precise code classifications.